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 Abstract 
 Neurobiological mechanisms that normally control food intake and energy expenditure can be 
overcome by environmental cues and by stress. Of particular importance is the influence of the 
mesolimbic reward pathway. In genetically susceptible individuals, problematic over-eating 
likely reflects a changing balance in the control exerted by homeostatic versus reward circuits 
that are strongly influenced by environmental factors such as stress. Both stress and activation 
of the reward pathway have been shown to increase food intake and promote a preference for 
palatable, high-energy foods. Recent research has focused on the important role of circulating 
and central neuropeptides that powerfully regulate the brain response to food cues. For ex-
ample, ghrelin has a potent positive effect on the motivational aspects of food intake, and 
central oxytocin may be involved in satiety. Thus, the decision to eat, or indeed to over-eat, 
involves a complex integrated neurobiology that includes brain centres involved in energy bal-
ance, reward and stress and their regulation by metabolic and endocrine factors. 
 Copyright © 2012 S. Karger GmbH, Freiburg 
 Introduction 
 Weight gain, obesity and psychological stress are pervasive elements of modern 
developed societies. The consequences of obesity and their threat to long-term health have 
been disseminated widely. But in contrast to the prevalence of tobacco smoking, for example, 
which has been dropping steadily in the UK since the 1970s, obesity levels are high and 
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rising, especially in children  [1] . The rise in obesity reflects a strong drive to consume food, 
especially energy-dense fatty or sugary foods, that continues to be present even when in 
positive energy balance. It seems that our stressful, modern environment has the capacity 
to inundate intrinsic neural mechanisms that homeostatically regulate appetite and food 
intake. Some have called this our ‘obesogenic’ environment: an environment that somehow 
promotes an increase in food intake, primarily via the ready availability of high-energy 
foods, and simultaneously a decrease in energy expenditure  [2] . 
 It is clear that forces other than homeostatic energy balance and food availability must 
drive food intake in the face of a surplus energy store. For those of us who live in the developed 
world at least, food supply is abundant, safe, varied and inexpensive. With virtually no coun-
teracting drive to rein in our drive to eat (except perhaps social or health pressures at a 
cognitive level), an increase in obesity may be inevitable. Here we assess the potential 
contribution from two other important drives: the effect of stress on feeding behaviour and 
the rewarding properties of consuming energy-dense food. We examine the potential neural 
substrates that may underlie the alterations in food intake and feeding behaviours asso-
ciated with reward and the exposure to stress.
 Modifying Food Intake: Established Targets 
 Soon after the discovery of leptin, a cascade of research revealed the pivotal role of 
certain hypothalamic nuclei in the control of food intake and energy expenditure  [3] . It was 
hoped that these neuronal pathways could be exploited to oppose the rising prevalence of 
diet-induced obesity and metabolic disorders in humans. However, it quickly became clear 
that only a very small minority of individuals suffering from obesity had tractable condi-
tions, typically genetic deficiencies in leptin or other components of the orexigenic pathways 
(most notably melanocortin-4 receptor mutations  [4] ). Despite the clear success in treating 
those rare monogenetic disorders of appetite, a startling degree of redundancy is evident in 
the systems that control food intake. For most of us, these hypothalamic pathways may not 
provide a successful target for anti-obesity therapy. For example, a major population of orex-
igenic neurons in the arcuate nucleus of the hypothalamus expresses several neurotrans-
mitters including neuropeptide Y (NPY) and agouti-related peptide (AgRP). Activation of 
these neurons (by ghrelin, for example), or activation of their downstream targets (by 
centrally administered NPY) in rodents normally evokes a strong feeding response  [5] . 
Surprisingly, this feeding response is maintained in NPY-knockout mice  [6] , in AgRP-
knockout mice and even in double NPY/AgRP-knockout mice that lack these peptides 
throughout development to maturity  [7] . Only complete ablation of NPY/AgRP neurons in 
adulthood leads to marked changes in feeding patterns and rapid starvation  [8] . These data 
give one example highlighting the redundancy of hypothalamic orexigenic drive. This drive 
depends on inputs that signal the physiological state of the organism: chronic energy stores 
via leptin and insulin and more acute nutritional state via gut-brain peptides such as ghrelin 
and PYY(3-36). 
 A second problem is that pathways known to have a pivotal role in appetite regulation 
also have a major influence on other physiological systems. For example, the arcuate 
nucleus contains a population of neurones that is the main source of the key anorexigenic 
peptide alpha melanocyte stimulating hormone (  MSH); this, signalling mainly through 
hypothalamic MC4 receptors, is a very potent inhibitor of feeding and was a major target 
of efforts to develop pharmaceutical approaches to moderating appetite. However, the 
same neurones, again acting via   MSH release and its effects on MC4 receptors, are also a 
potent stimulator of sexual behaviour  [9] . It seems likely that the motivation to eat and the 
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motivation to reproduce, being mutually exclusive, are reciprocally regulated – so any 
attempt to intervene pharmacologically at this level may have important consequences for 
other behaviours.
 The hypothalamic orexigenic pathways are complex, and, despite more than a decade 
of research, few drug targets have been delineated and even fewer therapeutic avenues have 
been utilised successfully. It may be of value to broaden our attention from the neural 
systems that monitor and control energy intake and expenditure to include other systems 
involved in changes in appetite in response to stress and our drive to experience rewarding 
behaviour. 
 Effects of Stress on Appetite 
 Stress is generally defined as an external challenge to an organism’s physiological equi-
librium. A stressful stimulus requires the organism to adapt its physiology or behaviour to 
counter the stressor’s harmful effects. During acute stress, the major adaptive pathway acti-
vated is the hypothalamic-pituitary-adrenal (HPA) axis  [10] . The paraventricular nucleus 
(PVN) of the hypothalamus integrates inputs from the periphery and other brain regions 
and is activated during stressful stimuli. Classically, corticotrophin-releasing hormone 
(CRH) is secreted from neuroendocrine cells of the PVN via the median eminence and into 
the portal blood supply. CRH regulates the release of adrenocorticotropic hormone (ACTH) 
from anterior pituitary corticotrophs. ACTH subsequently acts on the adrenal cortex to 
promote glucocorticoid secretion which, in turn, has several dramatic but short-term effects 
to enhance metabolism and promote attentiveness and preparedness in the organism. 
Typical acute effects of glucocorticoid release are conservation of blood glucose, an increased 
blood pressure and a diversion of blood flow from the gastrointestinal tract to the skeletal 
muscles and brain. These acute effects are terminated by the negative feedback effects of 
glucocorticoids at both the anterior pituitary and the brain – including especially the PVN, 
where glucocorticoids trigger the production of endocannabinoids by the CRH neurones, 
which in turn act presynaptically to suppress afferent input to those neurones.
 Given that the objective of the stress response is to preserve homeostasis in the short 
term, it may be counterintuitive to suppose that stress could increase food intake. During 
stress, time spent searching for, consuming and digesting food may be better spent defending 
against the stressor itself. Indeed, many studies in rats have demonstrated that chronic 
stressors such as daily restraint or immobilisation decrease food intake and that this is 
dependent on the duration and intensity of the stress  [11] . However, glucocorticoid admin-
istration stimulates palatable food intake in adrenalectomised rats  [12], and stressful 
stimuli have been shown to have orexigenic effects. If offered palatable, high-energy food in 
addition to the normal laboratory diet, rats undergoing dietary restriction increase their 
intake of palatable food in response to chronic foot shock stress  [13] . Similarly, rats experi-
encing a chronic tail pinch stress gain more weight when offered a palatable, high-energy 
diet compared to animals on a standard diet  [14] . 
 Like physical stressors, other types of stress have a variety of effects on appetite 
including an increase in food intake and body weight. Social stress in humans is considered 
to be commonplace in modern society, and a commonly used model of social stress in rats is 
the ‘visible burrow model’  [15] . In this model, a group of male rats is housed together, and a 
hierarchy naturally develops where one male rat becomes dominant and the others become 
subordinate. During this process all of the rats suffer stress and have a reduced food intake. 
However, once the hierarchy is established, subordinate animals become further stressed, 
displaying a higher basal level of plasma corticosterone than the dominant animal. Subor-
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dinate animals’ food intake remains reduced, and they lose body weight, whereas the 
dominant rat restores its food intake and tends to maintain body weight. Upon termination 
of the chronic social stress, both dominant and subordinate animals increase their body 
weight but only the subordinate animals are hyperphagic; thus, after recovery from social 
stress, subordinate rats have a larger increase in adipose tissue than the dominant animal. 
This effect is amplified when rats are fed a high-fat diet  [16] , suggesting that a consequence 
of chronic social stress is to increase food intake in a way that favours the intake of high-
energy foods, and that this can lead to adiposity. 
 The Importance of Reward in Appetite 
 Many activities necessary to life and its perpetuation, such as sexual behaviour and 
eating, are pleasurable. The pleasure associated with these behaviours influences future 
behaviour, making an organism more likely to engage in these activities again. Interest is 
now increasing in the neural mechanisms that underlie these non-homeostatic, hedonistic 
aspects of energy balance. Energy-dense foods are powerful rewards and their rewarding 
properties encourage their consumption even during positive energy balance. Repeated 
consumption can lead to conditioning : a learned association between the food stimuli (taste, 
smell, texture) and an expected reward  [17] . Indeed, obese individuals show a stronger pref-
erence for palatable (high-fat, high-carbohydrate) food than lean individuals, presumably 
due to a strengthened experience of reward  [18] . The evolutionary advantages of these 
drives are obvious; they alert an organism to the presence of high-energy foods and 
encourage the accumulation of energy stores during times of increased availability. However, 
for humans in the developed world at least, this beneficial drive has transformed into a 
burden.
 Reward mechanisms primarily involve the mesolimbic system. The role of dopamine 
neurones in the mesolimbic pathway (ventral tegmental area (VTA) – nucleus accumbens 
(NAcc) – frontal cortex/amygdala) and the control of motivation to eat and drink has been 
investigated extensively  [19] . As well as projecting to the frontal cortex, the shell of the NAc 
sends inhibitory inputs to the lateral hypothalamus  [20] . Palatable food stimulates the 
release of dopamine in the mesolimbic system and results in repeated self-administration, 
in other words hyperphagia  [21] . It has been suggested that low dopamine release may be 
related to obesity  [22] and that the mesolimbic system may be dysregulated in obesity, such 
that a state of ‘reward deficiency’ exists  [23] . In support of this hypothesis, rats fed an unre-
stricted palatable diet develop a reduced sensitivity to electrical self-stimulation of the 
mesolimbic pathway, suggesting that frequent intense activation of the reward pathway by 
feeding leads to a desensitisation or dysregulation of that pathway. Furthermore, these rats 
exhibit diet-induced hyperphagia even when conditioned to expect a painful foot shock 
during the feeding session  [24], indicating that they receive a sufficient reward from 
palatable food intake to overcome the threat of a concurrent aversive stimulus. A funda-
mental role for the dopaminergic mesolimbic system is revealed in dopamine-deficient 
mice (created by deleting tyrosine hydroxylase globally then restoring the enzyme only in 
noradrenergic neurones). These transgenic mice are hypoactive and aphagic  [25] , and their 
aphagia results in death from starvation in a few weeks. These effects can be prevented by 
L-DOPA administration; treated dopamine-deficient mice become hyperactive compared 
to controls and begin to eat voraciously. Similarly, deletion of both dopamine D1 and D2 
receptor leads to death by starvation after a few weeks, even in animals nursed by hand 
 [26] .
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 Ghrelin, Leptin and a Link between Stress, Reward and Appetite 
 The reward pathway is modifiable by several peptides that are involved in food intake 
( fig. 1 ). Two of the key peptides involved in regulating food intake are ghrelin, an orexigenic 
hormone secreted from the stomach in progressively increasing amounts since the last 
meal, and leptin, an appetite-inhibiting hormone secreted from adipocytes which circulates 
at concentrations proportional to total body fat mass. The VTA expresses ghrelin receptors 
 [27], and ghrelin administration to the VTA causes dopamine release  [28] and increases in 
food intake  [29] , notably the intake of (and preference for) rewarding/palatable food  [30] . 
Indeed, central ghrelin signalling, via GHS-R1A, appears to be important for food reward 
 [30] , for motivated behaviour for rewarding foods  [31, 32] and also for the reward asso-
ciated with artificial rewards such as alcohol  [33] , cocaine and amphetamine  [34] . In brain 
slices, VTA dopamine neurones are excited in vitro by ghrelin  [29] . In contrast, ghrelin can 
potentiate  [28, 29] or, depending on feeding state, inhibit  [35] dopamine signalling in the 
mesolimbic system, a complementary effect to that seen in the hypothalamus. Thus, within 
the mesolimbic system ghrelin targets a key pathway involved in reward reinforcement, 
especially in the motivation for natural and artificial rewards.  
 Besides its well-known effects at sites in the hypothalamic arcuate nucleus, leptin has 
also been suggested to act upon reward systems involved in the hedonic control of food 
intake. Dopamine neurones in the VTA also express receptors for leptin  [36] ; the actions of 
leptin are inhibitory (at least in brain slices in vitro) and, as suggested by a conditioned place 
preference test, are independent of leptin’s effects on feeding in the hypothalamus. Leptin 
suppresses dopamine signalling in the mesolimbic system via leptin receptor-expressing LH 
neurons that innervate the VTA  [37, 38], and administration of exogenous leptin attenuates 
self-stimulation of NAcc dopamine release  [39] . Selective knockout of leptin receptor in the 
lateral hypothalamus (one of the targets of NAcc output) of rats fed a high-fat diet causes an 
increase in food intake, body weight and adiposity. Selective knockout of leptin receptors in 
the midbrain restored the palatable diet-induced suppression of NAcc dopamine content 
 [40] . In other words, these data suggest that leptin acts at the mesolimbic system to restrain 
responses to food rewards, thereby suppressing the rewarding properties of feeding.
 Acute stress, including psychological  [41] and starvation stress  [42], increases plasma 
ghrelin levels. Conversely, ghrelin, at concentrations within the normal physiological range, 
stimulates the HPA axis, increasing hypothalamic CRF mRNA expression and raising plasma 
corticosterone levels  [42] . It has been suggested that glucocorticoids may have permissive 
effects for ghrelin’s orexigenic and fat-accumulating effects  [43] . Anxiety and depression are 
often associated with stress. In rodents, acute peripheral injections of ghrelin as well as 
central injections (into the brain ventricles or into specific parenchymal targets such as the 
amygdala, dorsal raphe nucleus and hippocampus) induce anxiety-like behaviour  [42, 44, 
45] . Furthermore, suppression of central ghrelin action by administration of antisense DNA 
for ghrelin causes a decrease in anxiety- and depression-like behaviour in rats  [46] . Lutter 
and colleagues  [47] , however, reported a decrease in anxiety- and depression-like behaviour 
in mice after peripheral ghrelin injection as well as after starvation. Given the chronicity of 
mood disorders in humans, the recent finding that chronic central ghrelin treatment of rats 
increases anxiety- and depression-like behaviour may be especially relevant  [48] .
 Elements of the HPA axis also express the leptin receptor, and there is evidence that leptin 
can suppress the stress response by acting at the hypothalamus and the adrenal gland. Leptin 
reduces CRH release from the mouse hypothalamus in vitro (but has no effect on ACTH release 
from primary cultures of rat pituitary)  [49] and inhibits basal and ACTH-evoked glucocor-
ticoid release from bovine adrenocortical cells in vitro  [50] . An increased sensitivity of the 
HPA axis has also been observed in the leptin-receptor deficient Zucker rat  [51] . Glucocorti-
D
ow
nl
oa
de
d 
by
: 
94
.1
74
.2
02
.1
47
 - 
7/
18
/2
01
3 
3:
04
:4
2 
PM
213Obes Facts 2012;5:208–220
 DOI: 10.1159/000338237 
 Published online: April 19, 2012 
 Menzies et al.: Neural Substrates Underlying Interactions between Appetite, Stress 
and Reward  
www.karger.com/ofa
© 2012 S. Karger GmbH, Freiburg
 Fig. 1. A schematic representation of some of the brain nuclei involved in food intake, stress and reward. 
In terms of energy balance, the best-characterised hypothalamic nucleus is the arcuate nucleus (ARC). The 
ARC expresses at least two functionally distinct populations of neurones. NPY neurones (which also 
express AgRP and GABA) are considered orexigenic. POMC neurones (which, in the arcuate, express CART 
and the POMC gene product   MSH) are considered anorexigenic. Both populations project to the hypotha-
lamic paraventricular nucleus (PVN), the ventromedial hypothalamus (VMH) and the lateral hypo-
thalamus (LH). Within the ARC, NPY/AgRP/GABA neurones directly inhibit POMC/CART neurones 
probably via local GABA release. Both ARC populations express receptors for leptin (released systemically 
from adipocytes) but sensitivity to ghrelin (released systemically from the stomach mucosa between 
meals) is restricted to NPY/AgRP/GABA neurones. Ghrelin and leptin both act at the predominantly gluta-
matergic (GLU) neurones of the VMH. GABAergic neurones of the LH also express leptin receptors. As well 
as its classical role in the release of corticotrophin-releasing hormone and activation of the HPA axis, the 
PVN also expresses oxytocin (OXT) and vasopressin (AVP) and releases both peptides centrally from a 
dendritic source. OXT and AVP can act at NPY/AgRP/GABA and POMC/CART neurones in the ARC and at 
the VMH. Apart from a leptin-sensitive LH projection to the VTA, the neuronal/neurohormonal networks 
linking the hypothalamus to the mesolimbic reward system are currently unclear, though dopaminergic 
(DA) neurones of the ventral tegmental area (VTA) involved in the reward pathway are sensitive to leptin 
and ghrelin. Other hypothalamic neurones not illustrated here are recognised to have a role in appetite, 
stress and reward. Notably, the orexin-expressing neurones of the lateral hypothalamus are involved in 
arousal and the motivation to eat and oxytocin and vasopressin neurones of the supraoptic nucleus (SON) 
are also sensitive to leptin, ghrelin and   MSH. 
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coids may have a reciprocal effect on circulating leptin levels, inhibiting levels in some human 
studies  [52], but not in others  [53] . In contrast to data showing an inhibitory effect of leptin 
on the stress response, lean humans generally show a reduced a HPA axis activation to various 
stressors compared to overweight individuals (who are likely to have higher plasma leptin 
levels than lean subjects). The mouse HPA axis is activated by leptin (increasing hypothalamic 
CRH and pituitary POMC mRNA and increasing circulating ACTH and corticosterone), though 
this effect is mediated by vasopressin acting via central V1a/b receptors  [54] and thus may 
represent an alternative pathway that is perhaps more relevant to chronic stress. 
 Vasopressin, Oxytocin and a Link between Stress, Reward and Appetite 
 During chronic stress in rodents, a major phenotypic change occurs in a key element of 
the HPA axis. Neurones in the PVN change their phenotype from expressing CRH to expressing 
a different peptide: vasopressin. Thus, when rats are exposed daily to episodes of restraint 
stress, each episode produces an activation of the HPA axis that results in a surge of ACTH 
and corticosterone secretion; initially this reflects CRH release, and the cells that are acti-
vated in the PVN show a prompt increase in both CRH mRNA expression and in vasopressin 
mRNA expression. But with each repetition of the stress, the increase in CRH mRNA 
expression is attenuated, while the increase in vasopressin mRNA expression is sustained 
or strengthened. Vasopressin receptor (V1bR) expression is also upregulated in the target 
tissue, the pituitary corticotroph  [55] . Vasopressin and the closely related peptide oxytocin 
have recently been found to have an unexpectedly strong link with appetite  [56] . Indeed, in 
a microarray study of the PVN that looked specifically for genes whose expression was 
downregulated in fasting and then upregulated by leptin, oxytocin and vasopressin were 
two of the most responsive genes identified.  [57, 58] . 
 The PVN is a source of several neuropeptides associated with the termination of feeding 
and is considered an important hypothalamic nucleus in the satiety response as lesions of 
the PVN cause hyperphagia and obesity  [59] . The PVN is innervated by both NPY- and   MSH-
containing fibres from the arcuate nucleus, and both oxytocin neurones and vasopressin 
neurones express MC4 receptors in abundance. V1aR-knockout mice have altered glucose 
homeostasis and are susceptible to diet-induced obesity  [60] . Central (but not peripheral) 
administration of oxytocin inhibits feeding, even in fasted rats  [61] , and male, but not female, 
oxytocin receptor-deficient mice display late-onset obesity  [62] . The activity of oxytocin 
neurones can be reduced by chronic high sucrose consumption  [63] and oxytocin has been 
suggested to inhibit carbohydrate intake selectively  [64] . 
 Vasopressin and oxytocin receptors are present in many brain regions, including in the 
arcuate nucleus and the adjacent ventromedial nucleus (VMH)  [65] . The arcuate nucleus has 
a well-established role in the detection and integration of long- and short-term blood-borne 
signals of hunger and satiety. Arcuate neurones integrate these signals and project to other 
hypothalamic areas involved in the control of energy balance such as the PVN and VMH  [66] . 
Since early lesioning studies, the VMH has been thought to have a key executive role in 
feeding behaviour, possibly as the central executor of satiety. The VMH expresses receptors 
for ghrelin, leptin and orexin, is strongly affected by systemic administration of the satiety-
inducing gut peptide cholecystokinin (CCK), and projects to numerous hypothalamic and 
extra-hypothalamic centres such as the arcuate, the PVN and the NAcc  [67] . The VMH is 
sensitive to activation of the major ascending satiety pathway from the vagus nerve to the 
nucleus of the solitary tract (NTS)  [68, 69] . 
 In addition to potential effects on the metabolic control of appetite, vasopressin and 
oxytocin are powerful modulators of social behaviour in rodents  [70] and humans  [71] . One 
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of the most striking examples is the attribution of behavioural differences between the 
closely related monogamous biparental prairie vole and the promiscuous asocial montane 
vole to differences in vasopressin V1a receptor expression throughout the brain  [72] . In 
addition to pair bonding and parental behaviour (as well as aggression), oxytocin and vaso-
pressin can modulate most forms of social recognition behaviour such as recognition of 
familiarity, sexual receptiveness, hierarchy and relatedness. Intracerebroventricular 
administration of an oxytocin receptor antagonist weakens social recognition (measured 
by their exploratory behaviour towards younger rats) in adult female rats  [73] . Similarly, 
oxytocin-knockout mice do not habituate to conspecifics  [74] .
 Vasopressin and oxytocin are also involved in anxiety-related behaviour and thus 
present themselves as strong candidates as modulators of motivational behaviour. V1bR-
knockout mice have lower ACTH and corticosterone levels compared to wild types after 
experiencing stressors  [75], and, although the anxiolytic effects of vasopressin and oxytocin 
are variable, it has been shown, using the elevated plus maze as a measure of anxiety-related 
behaviour, that administration of a V1a antagonist reduces anxiety  [76] . Male V1bR-knockout 
mice display less anxiety-related behaviour than wild-type males when assessed by a 
number of measures including the elevated plus maze and the open field test  [77] . The acute 
forced swim test is considered a good model of depression in rodents and is associated with 
increased ACTH levels. Forced swimming results in an increase in intrahypothalamic vaso-
pressin release  [78], indicating that increased vasopressin release may be involved in the 
onset or maintenance of depression in the model. Indeed, central administration of a V1aR 
antagonist during the forced swim test has an antidepressant effect demonstrated by an 
increase in the time spent struggling  [79] . 
 Oxytocin is generally considered to have anxiolytic effects but these can sometimes be 
difficult to distinguish from pro-social behaviours  [56] . Nevertheless, central adminis-
tration of oxytocin attenuates corticosterone release in response to a noise stress in rats 
and proves to be anxiolytic in the elevated plus maze test  [80] . Oxytocin may also be involved 
in depression: the neuropeptide is antidepressive in the forced swim test; the reduction in 
immobility being dependent on the dose and duration of treatment  [81] .  
 In humans clear gender differences exist in the amounts and distribution of adipose 
tissue; women tend to have more adipose tissue and less lean mass than men, and women 
are more prone to obesity. The hypothalamic appetite-regulating circuits express high 
densities of receptors for the ovarian hormones oestrogen and progesterone, and deletion 
of the ER  oestrogen receptor gene leads to obesity  [82] . However, the mechanistic implica-
tions are little studied. In several rodent models of targeted inactivation of specific genes 
implicated in appetite regulation, there is a gender difference in body weight phenotype. As 
described above, male transgenic mice deficient in the receptor for oxytocin are obese while 
females remain within a normal weight range but are prone to diet-induced obesity  [62] . One 
interpretation is that in females, the rewarding aspects of food are a greater determinant of 
intake than in males, which respond more strongly to the loss of a component of satiety 
signalling. 
 Questions and Objectives 
 We hypothesise that neuropeptides involved in the stress response (particularly vaso-
pressin and oxytocin) have effects on the responsiveness of neurons in the appetite-regu-
lating regions of the hypothalamus to appetite-related stimuli such as leptin and ghrelin. We 
also predict that neurones which regulate eating behaviour will be affected by mediators of 
reward and mood such as opioids, cannabinoids and serotonin, and that effects of stress- 
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and reward-mediating neurotransmitters may differ between males and females. Indeed, it 
is well-recognised that gender differences are seen in the stress response  [83] . Gender 
differences in brain region activation have also been reported in hedonic responses to visual 
food stimuli in humans  [84] . Certain eating disorders proposed to involved reward dysreg-
ulation (such as anorexia nervosa) have a unequal distribution between the sexes, with the 
prevalence among women being markedly higher  [85] .
 The importance of the pre- and perinatal environment must also be considered. Maternal 
diet-induced obesity in rats results in offspring that are obese and hyperphagic  [86], and 
early overfeeding of rats hastens the development of diet-induced leptin resistance  [87] . 
Furthermore, offspring of rats that experienced variable swim, restraint and social stresses 
during pregnancy have larger fat stores, are hyperleptinaemic and insulin-resistant and are 
more susceptible to diet-induced obesity even when their mothers were not fed a high-fat 
diet during pregnancy  [88] . 
 There are major gaps in our knowledge and understanding, and current research is 
directed at filling these, with specific objectives that include:
 i) To establish the effects of stress-related neuropeptides (oxytocin and vasopressin) on 
neuronal pathways that regulate food intake.
 ii) To establish the effects of reward-related neurotransmitters (opioids and cannabi-
noids) on neuronal pathways that regulate food intake.
 iii) To determine the neural substrates within the reward and stress pathways that 
respond to neuropeptide modulators of food intake.
 iv) To establish the effects of ovarian steroids (oestrogen and progesterone) on neuronal 
pathways that regulate food intake.
 v) To characterise the mechanisms underlying chronic changes in metabolism after 
prenatal stress and/or maternal obesity.
 How Science Can Inform Health Policy 
 New information regarding the neurobiological response to obesogenic food and its 
regulation by brain areas involved in reward, stress and mood, as well as by environmental 
cues and metabolic hormones, is important for informing policy at many levels. For example, 
the idea that food potentially has addictive properties can reinforce advice on nutrition and 
diet that certain foods and combinations of food not only have a caloric value but also that 
increased consumption of them increases risk of obesity through enhancing food addiction. 
Those informing policy within the food industry face the challenge of producing healthy 
rewarding foods. Finally, the research area has considerable opportunity to influence policy 
within the pharmaceutical sector, for which drugs targeting key emerging neurobiological 
targets without adverse effects on related neurobiological mechanisms must be given 
urgent priority. 
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